HC Wainwright Reiterates Buy Rating on Biomea Fusion, Keeps $4 Target

HC Wainwright reiterated its Buy rating and $4.00 price target on Biomea Fusion. The target implies 217.5% upside from the Oct. 13 close of $1.26.